Determinants of Clostridium difficile infection incidence across diverse United States geographic locations

Open Forum Infectious Diseases

Volumn 1, Issue 2, 2014, Pages

  Lessa, Fernanda C ^a   Mu, Yi ^a   Winston, Lisa G ^b   Dumyati, Ghinwa K ^c   Farley, Monica M ^d,e   Beldavs, Zintars G ^f   Kast, Kelly ^g   Holzbauer, Stacy M ^h   Meek, James I ⁱ   Cohen, Jessica ^a,j   Clifford McDonald, L ^a   Fridkin, Scott K ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ATLANTA VA MEDICAL CENTER   (United States)

^f OREGON HEALTH AUTHORITY   (United States)

^g Colorado Department of Public Health and Environment ^*  (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ YALE UNIVERSITY   (United States)

^j ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED INFECTION; FECES ANALYSIS; FEMALE; GENDER; HEALTH CARE UTILIZATION; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SENESCENCE; SOCIAL DETERMINANTS OF HEALTH; UNITED STATES;

EID: 84938966225     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu048     Document Type: Article

References (39)

1. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12:409-15.
2. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficilerelated mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13:1417-9.
3. Burckhardt F, Friedrich A, Beier D, Eckmanns T. Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis 2008; 14: 691-2.
4. Gravel D, Miller M, Simor A, et al. Canadian Nosocomial Infection Surveillance Program. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48:568-76.
5. Hall AJ, Curns AT, McDonald LC, et al. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012; 55:216-23.
6. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55(Suppl 2):S88-92.
7. Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1201-5.
8. Wilcox MH, Mooney L, Bendall R, et al. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008; 62:388-96.
9. Campbell RJ, Giljahn L, Machesky K, et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009; 30:526-33.
10. Pawar D, Tsay R, Nelson DS, et al. Burden of Clostridium difficile infection in long-term care facilities in Monroe County, New York. Infect Control Hosp Epidemiol 2012; 33:1107-12.
11. Chitnis AS, Holzbauer SM, Belflower M, et al. Epidemiology of community-associated Clostridium difficile infection, 2009-2011. JAMA Intern Med 2013; 173:1359-67.
12. Lucado J, Gould C, Elixhauser A. Clostridium difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research (US); 2006-2012. Available at: http://www.ncbi.nlm.nih.gov/books/NBK92613/pdf/sb124.pdf. Accessed 14 July 2014.
13. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365:1693-703.
14. Kutty PK, Woods CW, Sena AC, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010; 16:197-204.
15. Centers for Disease Control and Prevention. Surveillance for communityassociated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:340-3.
16. Brecher SM, Novak-Weekley SM, Nagy E. Laboratory Diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 2013; 57:1175-81.
17. Fong KS, Fatica C, Hall G, et al. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol 2011; 32:932-3.
18. Moehring RW, Lofgren ET, Anderson DJ. Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. Infect Control Hosp Epidemiol 2013; 34:1055-61.
19. Gould CV, Edwards JR, Cohen J, et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 2013; 57:1304-7.
20. Centers for Disease Control and Prevention. Measuring the scope of Clostridium difficile infection in the United States. Available at: http://www.cdc.gov/hai/eip/clostridium-difficile.html. Accessed 17 July 2013.
21. Health Resources and Service Administration, U.S. Department of Health and Human Services. Area Resource File. Available at: http:// arf.hrsa.gov/. Accessed 26 June 2013.
22. Centers for Disease Control and Prevention. Risk adjustment for Healthcare Facility-Onset C. difficile and MRSA Bacteremia Laboratoryidentified Event Reporting in NHSN. Available at: http://www.cdc.gov/ nhsn/PDFs/mrsa-cdi/RiskAdjustment-MRSA-CDI.pdf. Accessed 21 October 2013.
23. Simor AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc 2010; 58:1556-64.
24. Hicks LA, Taylor TH Jr, Hunkler RJ. U.S. outpatient antibiotic prescribing
25. N Engl J Med 2013; 368:1461-2.
26. Ginaldi L, De Martinis M, D'Ostilio A, et al. The immune system in the elderly: II. Specific cellular immunity. Immunol Res 1999; 20:109-15.
27. Unger JA, Whimbey E, Gravett MG, et al. The emergence of Clostridium difficile infection among peripartum women: a case-control study of a C. difficile outbreak on an obstetrical service. Infect Dis Obstet Gynecol 2011; 2011:267249.
28. Kuntz JL, Yang M, Cavanaugh J, et al. Trends in Clostridium difficile infection among peripartum women. Infect Control Hosp Epidemiol 2010; 31:532-4.
29. Fekety R, McFarland LV, Surawicz CM, et al. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997; 24:324-33.
30. Bertakis KD, Azari R, Helms LJ, et al. Gender differences in the utilization of health care services. J Fam Pract 2000; 49:147-52.
31. Majeed A, Moser K. Age-and sex-specific antibiotic prescribing patterns in general practice in England and Wales in 1996. Br J Gen Pract 1999; 49:735-6.
32. Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune disease in the United States. Clin Immunol Immunopathol 1997; 84:223-43.
33. Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat 13 2006(159):1-66.
34. Kullgren JT, Galbraith AA, Hinrichsen VL, et al. Health care use and decision making among lower-income families in high-deductible health plans. Arch Intern Med 2010; 170:1918-25.
35. Lambert PJ, Dyck M, Thompson LH, et al. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infect Control Hosp Epidemiol 2009; 30:945-51.
36. Norén T, Akerlund T, Bäck E, et al. Molecular epidemiology of hospitalassociated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 2004; 42:3635-43.
37. Stevens V, Dumyati G, Fine LS, et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011; 53:42-8.
38. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-55.
39. Sharp S, Gilligan P. A practical guidance document for the laboratory detection of toxigenic Clostridium difficile. Washington, DC: American Society for Microbiology, 2010. Available at: http://www. asm.org/images//Clinical/clostridiumdifficile9-21.pdf. Accessed 7 March 2014.